CGP 25454A

CGP 25454A Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:CGP 25454A
CAS:104391-26-6
Purity:98.00% Package:10 mg;100 mg;200 mg;5 mg;50 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:CGP 25454A
CAS:104391-26-6
Purity:99% Package:$280.9/5mg;$480.9/10mg;$960.9/50mg;$1650.9/100mg;Bulk package Remarks:99%
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Products Intro: Product Name:CGP 25454A
CAS:104391-26-6
Purity:>98% Package:1500RMB/1mg
Company Name: Musechem  
Tel: +1-800-259-7612
Email: info@musechem.com
Products Intro: Product Name:CGP 25454A
CAS:104391-26-6
Purity:>98% HPLC Package:10mg;100mg;1g Remarks:Reagent Grade
Company Name: DC Chemicals  
Tel: 021-58447131 13564518121
Email: sales@dcchemicals.com
Products Intro: Product Name:CGP-25454A
CAS:104391-26-6
Purity:98% HPLC Package:100mg,250mg,1g
CGP 25454A Basic information
Product Name:CGP 25454A
Synonyms:CGP 25454A;CGP25454A;CGP 25454A
CAS:104391-26-6
MF:C15H21Cl2N3O2
MW:346.25
EINECS:
Product Categories:
Mol File:104391-26-6.mol
CGP 25454A Structure
CGP 25454A Chemical Properties
storage temp. Store at -20°C
solubility DMSO : ≥ 3.5 mg/mL (10.11 mM)
form Solid
color White to off-white
Safety Information
MSDS Information
CGP 25454A Usage And Synthesis
Biological ActivityCGP 25454A is a novel and selective presynaptic dopamine autoreceptor antagonist.
in vitroCGP 25454A increase the field-stimulated [3H]- and [14C]-overflow from rat striatal slices preloaded with [3H]dopamine and [14C]choline, indicating that CGP 25454A is able to enhance the release of both dopamine (DA) and acetylcholine (ACh). However, CGP 25454A is 12.9 times more potent in increasing, by 1/6 of the apparent maximal increase, the release of [3H]DA than that of [14C]ACh.
in vivoCGP 25454A increase [3H]spiperone binding to receptors of the D2 family in rat striatum by 90-110% (ED50: 13 mg/kg i.p.). As a similar increase in [3H]spiperone binding is found with a variety of agents which increase the synaptic concentration of endogenous DA, the effect of CGP 25454A most probably reflects an enhanced release of DA under in vivo conditions. At 30-100 mg/kg, CGP 25454A inhibit [3H]spiperone binding in the pituitary of the same animals as a result of a blockade of postsynaptic DA receptors.
CGP 25454A Preparation Products And Raw materials
Tag:CGP 25454A(104391-26-6) Related Product Information